Targeting B cell receptor signalling in cancer: preclinical and clinical advances

JA Burger, A Wiestner - Nature Reviews Cancer, 2018 - nature.com
B cell receptor (BCR) signalling is crucial for normal B cell development and adaptive
immunity. BCR signalling also supports the survival and growth of malignant B cells in …

[HTML][HTML] Regulation of NLRP3 inflammasome by phosphorylation

N Song, T Li - Frontiers in immunology, 2018 - frontiersin.org
The cytosolic pattern recognition receptor (PRR) NOD-like receptor family, pyrin domain
containing 3 (NLRP3) senses a wide range of pathogen-associated molecular patterns …

Roles and regulation of microglia activity in multiple sclerosis: insights from animal models

F Distéfano-Gagné, S Bitarafan, S Lacroix… - Nature Reviews …, 2023 - nature.com
As resident macrophages of the CNS, microglia are critical immune effectors of inflammatory
lesions and associated neural dysfunctions. In multiple sclerosis (MS) and its animal …

A crucial role for the p110δ subunit of phosphatidylinositol 3-kinase in B cell development and activation

E Clayton, G Bardi, SE Bell, D Chantry… - The Journal of …, 2002 - rupress.org
Mice lacking the p110δ catalytic subunit of phosphatidylinositol 3-kinase have reduced
numbers of B1 and marginal zone B cells, reduced levels of serum immunoglobulins …

Inhibition of Btk with CC-292 provides early pharmacodynamic assessment of activity in mice and humans

EK Evans, R Tester, S Aslanian, R Karp… - … of Pharmacology and …, 2013 - ASPET
Targeted therapies that suppress B cell receptor (BCR) signaling have emerged as
promising agents in autoimmune disease and B cell malignancies. Bruton's tyrosine kinase …

Coupling of STIM1 to store-operated Ca2+ entry through its constitutive and inducible movement in the endoplasmic reticulum

Y Baba, K Hayashi, Y Fujii… - Proceedings of the …, 2006 - National Acad Sciences
Depletion of intracellular calcium (Ca2+) stores induces store-operated Ca2+ (SOC) entry
across the plasma membrane (PM). STIM1, a putative Ca2+ sensor in the endoplasmic …

Bleeding by Bruton tyrosine kinase-inhibitors: dependency on drug type and disease

P von Hundelshausen, W Siess - Cancers, 2021 - mdpi.com
Simple Summary Bruton tyrosine kinase (Btk) is expressed in B-lymphocytes, myeloid cells
and platelets. Since the launch of the first in class Btk-inhibitor (BTKi) ibrutinib in 2013, the …

Discovery of GS-9973, a selective and orally efficacious inhibitor of spleen tyrosine kinase

KS Currie, JE Kropf, T Lee, P Blomgren… - Journal of medicinal …, 2014 - ACS Publications
Spleen tyrosine kinase (Syk) is an attractive drug target in autoimmune, inflammatory, and
oncology disease indications. The most advanced Syk inhibitor, R406, 1 (or its prodrug form …

Calcium signalling and cell-fate choice in B cells

AM Scharenberg, LA Humphries… - Nature Reviews …, 2007 - nature.com
Alterations in the cytosolic concentration of calcium ions (Ca2+) transmit information that is
crucial for the development and function of B cells. Cytosolic Ca2+ concentration is …

The role of Bruton's tyrosine kinase in autoimmunity and implications for therapy

LJ Crofford, LE Nyhoff, JH Sheehan… - Expert review of clinical …, 2016 - Taylor & Francis
Bruton's tyrosine kinase (BTK) mediates B cell signaling and is also present in innate
immune cells but not T cells. BTK propagates B cell receptor (BCR) responses to antigen …